Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism-Reference-Cited by-同舟云学术

Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism

Published:2018-12-19 Issue:1 Volume:57 Page:10-13
ISSN:0012-6543
Container-title:Drug and Therapeutics Bulletin
language:en
Short-container-title:DTB

Author:

Shankar Rohit,Wilcock Mike,Oak Katy,McGowan Paula,Sheehan Rory

Publisher

BMJ

Subject

Pharmacology (medical),General Medicine

Reference19 articles.

1. The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study

2. National Institute for Health and Care Excellence, 2015. Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11) [online]. Available: https://www.nice.org.uk/guidance/ng11 [Accessed 22 October 2018].

3. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview

4. Prescribing psychotropic drugs to adults with an intellectual disability;Trollor;Aust Prescr,2016

5. Department of Health, 2012. Transforming care: a national response to Winterbourne View Hospital [online]. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/213215/final-report.pdf [Accessed 22 October 2018].

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability;Expert Review of Clinical Pharmacology;2024-08-13

2. Mental Health in People with Intellectual and Developmental Disabilities;Contemporary Clinical Neuroscience;2024

3. Clinical characteristics of people with intellectual disability admitted to hospital with constipation: identifying possible specific high‐risk factors;Journal of Intellectual Disability Research;2023-11-30

4. Appropriateness of psychopharmacological therapies to psychiatric diagnoses in persons with autism spectrum disorder with or without intellectual disabilities: a cross-sectional analytic study;Expert Opinion on Drug Safety;2023-09-19

5. Non-pharmacological and pharmacological interventions for the reduction or prevention of topographies of behaviours that challenge in people with intellectual disabilities: a systematic review and meta-analysis of randomised controlled trials;The Lancet Psychiatry;2023-09